4.8 Article

Highly Biocompatible Carbon Nanodots for Simultaneous Bioimaging and Targeted Photodynamic Therapy In Vitro and In Vivo

Journal

ADVANCED FUNCTIONAL MATERIALS
Volume 24, Issue 37, Pages 5781-5789

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/adfm.201400961

Keywords

carbon nanodots; photodynamic therapy; targeted therapy; drug delivery; bioimaging; fluorescence; cancer therapy

Funding

  1. National Research Foundation of Korea - Korean Government [2010-0028684, 2011-0017356]
  2. Research Center Program of Institute for Basic Science (IBS) [EM1402]
  3. Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A091047]
  4. Ministry of Science, ICT & Future Planning, Republic of Korea [IBS-R008-D1-2014-A00] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
  5. National Research Foundation of Korea [2010-0028684, 2011-0017356] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Photosensitizers (PSs) are light-sensitive molecules that are highly hydrophobic, which poses a challenge to their use for targeted photodynamic therapy. Hence, considerable efforts have been made to develop carriers for the delivery of PSs. Herein, a novel design is described of highly biocompatible, fluorescent, folic acid (FA)-functionalized carbon nanodots (CDs) as carriers for the PS zinc phthalocyanine (ZnPc) to achieve simultaneous biological imaging and targeted photodynamic therapy. FA is modified on PEG-passivated CDs (CD-PEG) for targeted delivery to FA-positive cancer cells, and ZnPc is loaded onto CD-PEG-FA via - stacking interactions. CD-PEG-FA/ZnPc exhibits excellent targeted delivery of the PS, leading to simultaneous imaging and significant targeted photodynamic therapy after irradiation in vitro and in vivo. The present CD-based targeted delivery of PSs is anticipated to offer a convenient and effective platform for enhanced photodynamic therapy to treat cancers in the near future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available